Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00988962 · ClinicalTrials.gov registry record · NA
Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid Therapy
A NA study of Substance Abuse, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT00988962: Completed NA study of Substance Abuse, sponsored by Brigham and Women's Hospital.
NCT00988962 is a NA study of Substance Abuse that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 84 participants, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00988962, a NA study of Substance Abuse, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic back pain patients are often dismissed from a pain center or a primary care practice when they are noncompliant with opioid therapy, instead of being offered treatments to reduce misuse and to improve compliance. Unfortunately, there are few treatment resources for such patients. This study seeks to remedy that problem, with the goal of reducing the rate of prescription opioid misuse among noncompliant patients through the use of novel tracking, education, and counseling interventions.
Conditions Studied
Interventions
- BEHAVIORAL cognitive behavioral training
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital Pain Management Center - Chestnut Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-06 |
| Phase | NA |
What the finished NCT00988962 record still lists
NCT00988962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 5,258-participant average among 58 other Substance Abuse trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Substance Abuse appearing as the primary indexed condition, and to 1 intervention - of which cognitive behavioral training is the first listed.
NCT00988962 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00988962 about?
NCT00988962 is a clinical study titled "Substance Abuse Treatment for High Risk Chronic Pain Patients on Opioid Therapy". Chronic back pain patients are often dismissed from a pain center or a primary care practice when they are noncompliant with opioid therapy, instead of being offered treatments to reduce misuse and to improve compliance. Unfortunately, there are few treatment resources for such patients. This study ...
What is the current status of trial NCT00988962?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2009-07. Estimated completion is 2011-06.
What conditions does trial NCT00988962 study?
This clinical trial studies the following conditions: Substance Abuse.
What interventions are being tested in trial NCT00988962?
The interventions under investigation include: cognitive behavioral training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00988962?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00988962 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00988962's enrollment target sits among peer trials
84 39th of 58 higher than 19 of 58 other Substance Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Testing ALERT With GTO in Middle Schools
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
The STop UNhealthy Substance Use Now Trial
RECRUITING · NA
-
The Trans-Led Care Study
RECRUITING · NA
-
Data2Action Oregon Project: Supporting Data-driven Decision-Making for Substance Use Services, Policy, and Overdose Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia